| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/08/2001 | WO2000054758A3 Method for delivering benzidine prostaglandins by inhalation |
| 02/08/2001 | WO2000051566A8 Scar reduction |
| 02/08/2001 | WO2000048617A3 Connective tissue softening |
| 02/08/2001 | WO2000048446A3 Use of antagonists of pg-e for the treatment of neuropathic pain |
| 02/08/2001 | WO2000024365A8 Treatment of skin with adenosine or adenosine analog |
| 02/08/2001 | WO2000007627A8 Topical delivery systems for active agents |
| 02/08/2001 | DE19937394A1 Fluorenderivate Fluoro derivatives |
| 02/08/2001 | DE19937116A1 Moxifloxacin Kochsalzformulierung Moxifloxacin saline formulation |
| 02/08/2001 | DE19937115A1 Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon An aqueous pharmaceutical formulation of moxifloxacin or salts thereof |
| 02/08/2001 | DE19936831A1 Verringerung von Cholesterinoxiden durch n-3-PUFA und Vitamin E Reduction of cholesterol oxides by n-3 PUFA and vitamin E |
| 02/08/2001 | DE19935763A1 Retinoid-containing emulsion for topical cosmetic or dermatological use, e.g. in skin regeneration or acne treatment, containing stabilizing combination of ascorbic acid and polyphenol compounds |
| 02/08/2001 | DE19935303A1 Oligonukleotide zur Inhibierung der Expression von humanem eg5 Oligonucleotides for inhibiting the expression of human Eg5 |
| 02/08/2001 | DE19935302A1 Konjugate und Verfahren zu deren Herstellung sowie deren Verwendung zum Transport von Molekülen über biologische Membranen Conjugates and methods for their preparation and their use for transporting molecules across biological membranes |
| 02/08/2001 | DE19935209A1 Treatment of urinary incontinence and related disorders, by increasing intracellular cyclic adenosine monophosphate concentration, e.g. using adenyl cyclase stimulant such as forskolin |
| 02/08/2001 | DE10037121A1 Antipyretic composition for treating intensively reared animals, comprising stable, concentrated paracetamol solution in polyethylene glycol and/or polypropylene glycol, added to drinking water or sprayed on feed |
| 02/08/2001 | DE10020237A1 Verwendung von N-Anisoyl-gamma-aminobuttersäure oder p-Anissäure zur Herstellung einer pharmazeutichen Zusammensetzung Use of N-anisoyl gamma-aminobutyric acid or p-anisic acid for preparing a composition pharmazeutichen |
| 02/08/2001 | CA2697207A1 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 02/08/2001 | CA2647796A1 Method of inhibiting osteoclast activity |
| 02/08/2001 | CA2393915A1 1,2-dihydro-1-oxo-pyrazino¬1,2-a|indole derivatives |
| 02/08/2001 | CA2391766A1 C-6 ring-substituted pyrido¬1,2-a|benzimidazole derivatives usefu l in treating central nervous system disorders |
| 02/08/2001 | CA2391348A1 Enhanced delivery via serpin enzyme complex receptor |
| 02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | CA2388297A1 Ophthalmic compositions containing antibiotics and nsaids |
| 02/08/2001 | CA2381004A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 02/08/2001 | CA2380644A1 2-pyrazolin-5-ones |
| 02/08/2001 | CA2380639A1 Cloning of the <i>streptomyces avermitilis</i> genes for glycosylation of avermectin aglycones |
| 02/08/2001 | CA2380631A1 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 02/08/2001 | CA2380608A1 Serotonergic benzofurans |
| 02/08/2001 | CA2380582A1 New cytotoxic pyrido[2,3,4-kl]acridine derivatives, their preparation and their therapeutic use |
| 02/08/2001 | CA2380545A1 Nucleic acid ligands to cd40ligand |
| 02/08/2001 | CA2380531A1 Benzofurylpiperazine serotonin agonists |
| 02/08/2001 | CA2380473A1 Tenascin-c nucleic acid ligands |
| 02/08/2001 | CA2380371A1 Thiourea and isothiourea derivatives for inhibiting ras-transformed cell growth |
| 02/08/2001 | CA2380295A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 02/08/2001 | CA2380081A1 Calcilytic compounds |
| 02/08/2001 | CA2380032A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | CA2380029A1 Benzenamine derivatives as anti-coagulants |
| 02/08/2001 | CA2380007A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | CA2379993A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | CA2379987A1 Opioid sustained-released formulation |
| 02/08/2001 | CA2379953A1 Assay for d-serine transport antagonist and use for treating psychosis |
| 02/08/2001 | CA2379918A1 Pharmaceuticals for neuropathic pain |
| 02/08/2001 | CA2379778A1 2-aminotetralin derivatives for the therapy of glaucoma |
| 02/08/2001 | CA2379703A1 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses |
| 02/08/2001 | CA2379663A1 Cartilage or bone matrix as a nucleic acid delivery vehicle |
| 02/08/2001 | CA2379660A1 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378942A1 Imidazole antiproliferative agents |
| 02/08/2001 | CA2378936A1 Potassium channel openers |
| 02/08/2001 | CA2378929A1 Serine proteases |
| 02/08/2001 | CA2378879A1 Serotonergic benzothiophenes |
| 02/08/2001 | CA2378878A1 Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
| 02/08/2001 | CA2378710A1 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders |
| 02/08/2001 | CA2378331A1 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | CA2378302A1 Thienopyranecarboxamide derivatives |
| 02/08/2001 | CA2378182A1 Compositions and methods for the treatment of tumors |
| 02/08/2001 | CA2378176A1 Heterocyclic compounds inhibiting angiogenesis |
| 02/08/2001 | CA2378155A1 Colloidal composition for esthetic correction |
| 02/08/2001 | CA2378140A1 Methods for transdifferentiation of body tissues |
| 02/08/2001 | CA2376927A1 Oxazinocarbazoles for the treatment of cns diseases |
| 02/08/2001 | CA2374383A1 Oxazolidinones and their use as antiinfectives |
| 02/08/2001 | CA2362785A1 Glucamine compounds for treating hepatitis virus infections |
| 02/08/2001 | CA2345753A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |
| 02/07/2001 | EP1074842A1 Catalytic anti-factor VIII allo-antibodies |
| 02/07/2001 | EP1074634A1 Method for the diagnosis or the prognosis of Alzheimer disease therapeutical composition for preventing or treating Alzheimer disease |
| 02/07/2001 | EP1074631A2 Compounds having glucuronic acid derivatives and glucosamine derivatives in the structure, process for producing the same and utilization thereof |
| 02/07/2001 | EP1074625A2 DNA vaccine against feline immunodeficiency virus |
| 02/07/2001 | EP1074623A1 ABC transporter |
| 02/07/2001 | EP1074592A1 Process for preparing beadlets containing fat-soluble substances |
| 02/07/2001 | EP1074559A1 Peptide nucleic acids |
| 02/07/2001 | EP1074558A1 Process for the preparation of mometasone furoate |
| 02/07/2001 | EP1074556A1 Phosphonic diester derivatives |
| 02/07/2001 | EP1074554A2 7-acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation |
| 02/07/2001 | EP1074553A1 7-Acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation |
| 02/07/2001 | EP1074542A1 Sulfonamide-containing indole compounds |
| 02/07/2001 | EP1074263A2 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoylate saturated hydroxy-fatty acid |
| 02/07/2001 | EP1074260A1 IL-12 Production inhibitor |
| 02/07/2001 | EP1074259A1 Preventives for alcoholic gastritis |
| 02/07/2001 | EP1074258A2 Methods and compositions for treating diseases and conditions of the eye |
| 02/07/2001 | EP1074257A1 2,7-Substituted octahydro-1H-pyrido (1,2-A)pyrazine derivatives as ligands for serotonin receptors |
| 02/07/2001 | EP1074256A2 Depolarizing skeletal muscle relaxants |
| 02/07/2001 | EP1074255A1 Medicinal compositions |
| 02/07/2001 | EP1074254A2 Use of plant polyphenols with vitamines for treating iron overload |
| 02/07/2001 | EP1074253A1 Oral preparations containing forskolin derivatives and process for producing medicinal preparations |
| 02/07/2001 | EP1074252A2 Composition comprising theanine for suppressing behaviour problems of pets |
| 02/07/2001 | EP1074251A1 Adhesive preparations |
| 02/07/2001 | EP1074248A1 Delivery system for biological material |
| 02/07/2001 | EP1074244A2 Topical composition comprising a tocopherol compound |
| 02/07/2001 | EP1074185A1 Incorporation of cholesterol lowering agents into confectionery dosage forms |
| 02/07/2001 | EP1073764A1 Membrane-permeant phosphoinositides |
| 02/07/2001 | EP1073762A1 Enzymatic resolvation for obtaining a (-)-3,4-trans-diarylchroman |
| 02/07/2001 | EP1073737A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/07/2001 | EP1073733A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY |
| 02/07/2001 | EP1073729A2 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 02/07/2001 | EP1073728A2 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 02/07/2001 | EP1073713A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae |
| 02/07/2001 | EP1073704A1 Stable carbanilide composition |
| 02/07/2001 | EP1073694A1 Trans-xanthophyll ester concentrates of enhanced purity and methods of making same |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073677A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES |